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A BST R AC T   
 
Aim: To evaluate the effects of theranekron in respect of autophagy on gastric cancer that is the fifth leading 
cancer type worldwide.  
Metods: In the present study, metastatic AGS and non-metastatic MKN-45 human gastric cell lines were used 
together with HEK-293 non-cancer cells as controls. Cytotoxic effect of theranekron besides appropriate 
treatment time was investigated through cell proliferation by using Cell Proliferation assay Kit (MTT) using 
different concentrations of the drug. The autophagic effect of the drug was determined using the LC3-GFP 
translocation assay and western blot analysis. All experiments were performed also using the ethanol since 
Tarantula cubensis spider was processed and diluted in 60% alcohol to generate as a drug.  
Results: MTT assay results demonstrated that the half maximal inhibitory concentration of theranekron was 
~100 μM, its effect was found to be significant at 6 hrs, and theranekron decreased the cell viability in all cell 
lines without specificity in respect to the increasing concentrations. Additionally, a significantly increased GFP 
accumulation was detected in the autophagosomes of the cells treated with theranekron compared to non-
treated cells, indicating the presence of autophagy.  
Conclusion: These findings were confirmed by LC3-I to LC3-II conversion with the western blot analysis. 
The data of ethanol experiments; however, demonstrated that ethanol also induced a cytotoxic effect and 
autophagic cell death. Our results suggested that theranekron results in cell death and stimulate autophagy 
process, but it is not specific for cancer cells since it represented similar results on non-cancer control cells. 
Moreover, the effect of theranekron on cell death might mostly occur through alcohol in which it is extracted. 
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Introduction 
Gastric cancer is a type of cancer that originates 
at the mucosa epithelia of the stomach and 
expands rapidly to the lining of the stomach. 
Mostly, it is developed as ulcer. The cancer may 
spread from the stomach to other parts of the 
body, particularly to the liver, lungs, bones, 
lining of the abdomen and lymph nodes through 
blood [1].  Globally, stomach cancer is the fifth 
leading cancer type and the third leading cause 
of death from cancer according to 2012 cancer 
statistics [2]. It is also fifth leading cancer at 
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men and sixth leading cancer type at women in 
Turkey according to 2016 cancer statistics [3]. 
Gastric cancer occurs most commonly in East 
Asia especially Japan and South Korea and 
Eastern Europe. It is observed mostly at ages of 
50 to 60 and occurs twice as often in males than 
females [2]. 
Theranekron® (Richter Pharma, Austria) is an 
alcoholic extract of the venom that is provided 
from a spider known as tarantula cubensis. 
Tarantula cubensis is the famous one among 
the venomous spiders and many therapeutic 
effects have been reported for its venom [4]. 
Theranekron is a homeopathic remedy that is 
used in cattle, horse, sheep, goat and dog. 
Homeopathy is a treatment method introduced 
by Dr. Samuel Hahnemann in the end of 18th 
century with the principle that ‘‘any substance 
causing symptoms of a disease in healthy 
people will cure similar symptoms in sick 
people’’. Mezger described the homeopathic 
effects of theranekron first time in 1977 [5]. 
Theranekron is used as a pharmaceutical 
compound serving in veterinary medicine with 
outstanding success for its antiphlogistic, 
necrotizing, and wound healing effects [4]. In 
the literature, the drug was studied in various 
fields such as many types of ulcer and abscess, 
peripheral nerve healing, as well as treating 
necrotic or proliferative cases in animals [6-9]. 
Koch and Stein reported first time that 
theranekron stimulate the demarcation of 
mammary gland tumors in dogs [10]. Later, 
Gultekin et al (2007) reported that theranekron 
application to the dogs resulted in regression 
and hardness of benign mammary tumors [11], 
and tarantula cubensis extract alters the degree 
of apoptosis and mitosis in canine mammary 
adenocarcinomas shown in 2015 [12].  
Autophagy is a tightly-regulated process 
involving the degradation of a cell's own 
components through the lysosomal machinery 
[13]. Autophagy plays an important role in the 
homeostasis of the organelles and protein, and 
maintains a balance between synthesis and 
degradation in cells [14]. During the 
distribution of the homeostasis, autophagy 
leads to the cell death through activating the 
signaling pathways. Autophagic cell death is 
distinct from the apoptotic cell death, but the 
relationship between autophagy and apoptosis 
is more complex. It was shown that autophagy 
can delay apoptotic death following DNA 
damage [15] as well as can trigger a form of cell 
death in the absence of apoptosis [16]. The aim 
of the present study was to evaluate the effects 
of the alcoholic extract Theranekron on the 
gastric cancer cells in respect of autophagy. 
 
Materials and Methods 
 
Culture of cells  
Metastatic gastric cancer cell line AGS, non-
metastatic gastric cell line MKN-45, and non-
cancerous cell line HEK-293 were purchased 
from American Type Culture Collection 
(ATCC, USA). The cells were cultured in 
Dulbecco's modified Eagle's medium (DMEM) 
(Sigma-Aldrich, Germany) containing 10% 
fetal bovine serum (FBS) (Sigma-Aldrich, 
Germany) and 1% penicillin-streptomycin 
(P/S) antibiotic solution (Sigma-Aldrich, 
Germany). Cells were grown in a 5% CO2 
incubator at 37˚C by replacing the medium 
every other day, and cells were passaged when 
they reached confluence.  
 
The half maximal inhibitory concentration 
and cytotoxic effect of theranekron  
AGS, MKN-45, and HEK-293 cells (1x104 
cells/well) were treated with different 
concentrations of theranekron (Richter Pharma, 
Austria) by diluting the drug with culture 
medium. One group of cells was also treated 
                                              Yenigun et al / Exp Biomed Res. 2021; 4(2):89-98 




with same dilutions of alcohol as control since 
the drug was extracted in ethanol. Following 
different time points, the Cell Proliferation Kit 
I (MTT) experiment was performed. Culture 
medium was mixed with thiazolyl blue 
tetrazolium bromide powder (Sigma-Aldrich, 
Germany) at a ratio of 5 mg/ml, and 10 μl was 
added to each well. The cells were incubated 
with the solution for 3 h at 37˚C until the color 
turned into blue. Then, all the solution was 
taken away from the wells and the formazan 
salts were dissolved through DMSO about 20 
min. The absorbance was measured at 540 nm. 
 
LC3-GFP translocation assay  
AGS, MKN-45, and HEK-293 cells were 
seeded into 6-well plate with 2 mL culture 
medium and transfected with plasmid coding 
LC3 fused with green fluorescence protein 
(GFP). For transfection, first plasmid was 
diluted in a tube with 125 l serum free medium 
at a ratio of 1 μg/100 μl. At the same time, 6 l 
Lipofectamine® 2000 (Invitrogen, USA) 
transfection reagent was diluted with 125 l 
serum free medium in another tube. After 5 
minutes of incubation time, both tubes were 
mixed and the mixture was then incubated at 
room temperature for 20 min to form lipid 
complexes. 250 l of mixture was then added 
into each well. Transfected cells were incubated 
in CO2 incubator for 24 h until the cells start to 
express LC3-GFP. Then, one group of 
transfected cells was treated with 100 µM 
theranekron and the other groups were treated 
with rapamycin as a positive control for 
autophagy and alcohol as negative control. 
Treated cells were incubated for 3, 6, and 12 
hours for the best result. The cells were 
analyzed under Epi Fluorescence Microscope 
(Nikon, Japan). 
 
LC3 protein analysis by western blot  
AGS, MKN-45, and HEK-293 cells were 
treated with theranekron and alcohol for 6 hrs, 
then they were detached from plate, washed 
with PBS, and the pellets were lysed with 100 
150 μl RIPA lysis buffer (Santa Cruz, USA). 
The protein concentration of the lysates was 
determined with Bradford protein assay reagent 
(Bio-Rad, USA) following the manufacturer's 
instructions. Each sample (20 μg) was loaded 
into a 10% separating acrylamide gel and 
electrophoresis was applied. After blotting, the 
membrane was incubated with LC3 (Cell 
Signaling Technology, USA) and β-actin 
(Santa Cruse Biotechnology, USA) primary 
antibodies at 4˚C. Images of the proteins were 
captured with a molecular imager (LI-COR 
Biosciences, USA) at a suitable time (change 
with respect to the primary antibody) after 
incubating the membranes with Western ECL 
Blotting Substrate (Bio-Rad, USA) for 5 min. 
 
Results 
Effect of theranekron on cell proliferation  
The initial step for evaluating the effect of 
theranekron on gastric cancer cells was to 
determine the half maximal inhibitory 
concentration of the drug. The results of MTT 
assay showed that the IC50 value of theranekron 
on these cells was ~100 μM. Moreover, the 
significant effect of theranekron was found to 
be at 6 hrs. Therefore, 100 μM theranekron was 
applied to cells for 6 hrs in the subsequent 
experiments. After appropriate time and 
concentration were determined, the viability of 
cancer and non-cancer cells treated was 
analyzed for effectiveness and uniqueness. The 
results showed that theranekron affected similar 
in both AGS and MKN-45 gastric cells as it 
affected in control HEK-293 cells (Figure 1).   
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Moreover, theranekron was provided 
commercially and it was extracted in 60% 
ethanol. For this reason, theranekron and 
alcohol’s cytotoxic effects were compared on 
gastric cancer and non-cancer cells to 
distinguish theranekron’s effect from alcohol.  
All gastric cancer and control cells were treated 
with theranekron and ethanol at the same 
dilutions for 6 hrs.  The results of proliferation 
assay demonstrated that alcohol showed similar 
results to theranekron (Figure 2). 
 
Theranekron’s autophagic effect in respect to 
the autophagy marker LC3  
Since it was observed that theranekron decrease 




























Figure 1.  Comparison of theranekron’s cytotoxic 
effects on AGS, MKN-45 gastric cancer and HEK-
293 control cells at 6 hrs with different 






















Figure 2.  Comparison of theranekron and alcohol effects on AGS, MKN-45 and HEK-293 cells following 
treatment with theranekron and ethanol. 
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Figure 3.  Autophagic effects of theranekron on (A) AGS, (B) MKN-45, and (C) HEK-293 cells displayed 
by LC3-GFP aggregation in the vacuoles of theranekron treated cells. 
 
Figure 4.  Comparison of autophagy effects of theranekron to ethanol on (A) AGS, (B) MKN-45, and (C) 
HEK-293 cells displayed by LC3-GFP aggregation in the vacuoles of theranekron and ethanol treated cells. 
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were carried out to investigate whether 
theranekron induce cell death through 
autophogic pathway. Initially, LC3 
translocation assay was performed to analyze 
autophagy in treated cells. The results 
demonstrated that theranekron induced 
autophagy in gastric cancer cell lines AGS and 
MKN-45 when applied for 6 hrs at the similar 
level with rapamycin that is an autophagy 
inducer (Figure 3A and 3B). However, it was 
observed that autophagy was also induced in 
control HEK-293 cells, so the autophagy 
induction was not unique to cancer cells (Figure 
3C).  
In addition to that, alcohol’s effect on 
autophagy was also tested on these cells since 
the drug was extracted in ethanol. According to 
the results, ethanol triggered authophagic cell 























there were less LC3 aggregated vacuoles in 
ethanol treated cells especially in HEK-293 
cells comparing to gastric cancer cells (Figure 
4A, 4B, 4C).  
To confirm the LC3 translocation assay’s 
results, theranekron treated gastric cancer and 
non-cancer control cells were analyzed for 
LC3-I to LC3-II conversion by western 
blotting, which is known as hallmark of 
autophagy. The results showed that theranekron 
induced autophagy in both AGS and MKN-45 
gastric cancer cells at 6 h. LC3-I (18 kDa) to 
LC3-II (16 kDa) conversion was clearly 
visualized in the treated cells. As in LC3 
translocation assay results, theranekron induced 
autophagy in gastric cancer cells similar to 
HEK-293 control cells. Moreover, the ethanol 
treatment resulted in the autophagy in all cell 

























Figure 5.  Autophagic effects of theranekron on AGS, MKN-45, and HEK-293 cells demonstrated by LC3-I 
(18 kDa) to LC3-II (16 kDa) conversion. All cell types were treated with theranekron, ethanol and rapamycin, 
separately, for comparison. 
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effect (Figure 5A, 5B, and 5C). This data also 
showed a consistency with LC3 translocation 
assay results.  These results showed that 
theranekron induced more extensive 
autophagic cell death in both cell types when 
compared to the ethanol treated cells. However, 
theranekron did not show a significant 
difference in the gastric cancer cells for 
autophagic cell death when compared to the 
HEK-293 control cells. 
 
Discussion 
In this study, the effects of theranekron on 
gastric cancer cells were investigated focusing 
on autophagic cell death. Gastric cancer is one 
of the most common gastrointestinal tumors 
and fifth leading cancer type, globally [2]. 
Autophagy is a tightly-regulated homeostatic 
process that involves degradation of cells’ own 
components through the lysosomal machinery. 
It is a major system to clear the defective or 
aging organelles and long-lived proteins in 
eukaryotic cells. It is reported that autophagy 
plays a dual role as tumor suppressor function 
at early stages while it plays an oncogenic 
function once the tumor is formed by providing 
cancer cells with survival contexts as nutrition 
[17]. Autophagy plays also tumor-suppressor 
and tumor-promoter role in gastric cancer [18]. 
Autophagy-related markers as Beclin1 might be 
considered as a potential marker of gastric 
carcinogenesis, aggressiveness and prognostic 
prediction, and as a target for gene therapy in 
gastric cancer [19] while autophagy inducers, 
such as rapamycin, show promise for gastric 
cancer treatment [20]. It was also reported that 
long-term Helicobacter pylori infection can 
disrupt autophagy process eventually 
promoting gastric cancer [21]. 
Theranekron is a homeopathic remedy that is 
mostly used in the veterinary medicine. It is an 
alcoholic extract produced by processing the 
whole spider known as Tarantula cubensis and 
diluting in 60% alcohol. There are many studies 
carried out with theranekron to present its 
beneficial effect in the veterinary medicine area 
such as wound healing [22], anti-inflammatory 
[23], and necrotizing action [4]. In addition to 
these studies, antibacterial effect of theranekron 
was evaluated, but they could not find 
significant antibacterial property of the venom 
[24]. Recently, theranekron’s effect on 
peripheral nerve healing was also studied, and 
it was found that theranekron decreases axonal 
and myelin damage after sciatic nerve injury 
[9].  
Beside of all these data, there is not much study 
investigated the theranekron’s effect on cancer. 
For the first time, Koch and Stein published a 
paper in 1980 about theranekron’s effect on 
dogs’ mammary gland tumors [10]. They 
demonstrated that theranekron stops tumor 
growth in canine mammary tumors by forming 
demarcation from surrounding tissue when it is 
used preoperatively a week for three times with 
the dosage of 3-6 ml depending on the body 
weight. It was observed that tumors became 
smaller, no reoccurrence was observed for 
years. Then, Gultiken and Vural demonstrated 
in their 2007 paper that Tarantula cubensis 
extract applications resulted in regression and 
hardness of benign mammary tumors while 
only hardness was detected in malignant 
mammary tumors in the dogs [11]. The same 
group then published another study in 2015 
about theranekron’s apoptotic effect on canine 
mammary tumors.  Pre- and post-treatment 
tumor tissues were immunohistochemically 
assessed and they showed that the expression of 
B-cell lymphoma 2 (Bcl-2) which is considered 
an important anti-apoptotic protein was found 
to be higher in pre-treatment compared to post-
treatment tissues. They concluded that the 
apoptotic index was low before treatment and 
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increased during treatment, so apoptotic cell 
death increased through theranekron treatment 
[12]. Beside these results, Ghasemi-Dizgah et 
al (2017) and Ayse et al (2017) demonstrated in 
their in vitro studies that theranekron increases 
cell death through apoptosis [25, 26]. In the 
current study, it was shown that theranekron 
leaded to cell death, but also presented that the 
cell death induced by theranekron was also 
through autophagic pathway. Moreover, it was 
also shown that the cell death could be triggered 
by alcohol in which theranekron was diluted. 
Finally, this study also indicated that alcohol 
triggered autophagic pathway supporting 
previous studies in the literature about alcohol 
induces autophagy [27, 28].  
The common ground of all studies performed 
before current study is that they had been 
carried out in vivo. In vitro cancer studies of 
theranekron is very limited in the literature. 
Moreover, autophagic effect of theranekron 
was not examined although its apoptotic effect 
was shown [25, 26]. In addition, ethanol, the 
solvent used to extract was not investigated in 
any study before to eliminate alcohol effect of 
theranekron. To our knowledge, the present 
study is the first to reveal the relationship 
between theranekron and autophagic cell death. 
Also, this is the first study to show theranekron 
may cause cell death through alcohol in which 
it is extracted.  
 
Conclusions 
In this study, it was demonstrated that 
theranekron result in cell death and stimulate 
the autophagy process, but it is not specific for 
cancer cells since it represented similar results 
on non-cancer cells. Moreover, the effect of 
theranekron on cell death might mostly occur 
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